US Stock MarketDetailed Quotes
NTRB Nutriband
- 4.850
- +0.080+1.68%
Close Nov 27 16:00 ET
- 4.850
- 0.0000.00%
Post 20:01 ET
53.82MMarket Cap-5987P/E (TTM)
4.975High4.640Low14.50KVolume4.640Open4.770Pre Close70.66KTurnover0.28%Turnover RatioLossP/E (Static)11.10MShares9.59552wk High4.32P/B24.76MFloat Cap2.22052wk Low--Dividend TTM5.11MShs Float10.560Historical High--Div YieldTTM7.02%Amplitude1.530Historical Low4.874Avg Price1Lot Size
About Nutriband Company
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.
Company Profile
SymbolNTRB
Company NameNutriband
Listing DateOct 1, 2021
Founded2012
CEOMr. Gareth Sheridan
MarketNASDAQ
Employees13
Fiscal Year Ends01-31
Address121 South Orange Avenue,Suite 1500
CityOrlando
ProvinceFlorida
CountryUnited States of America
Zip Code32801
Phone1-407-377-6695
Websitehttp://www.nutriband.com
Company Executives
- Name
- Position
- Salary
- Gareth Sheridan
- Chief Executive Officer and Director
- 378.67K
- Dr. Alan Smith, PhD
- Chief Operating Officer and President of 4P Therapeutics
- 236.49K
- Gerald Goodman
- Chief Financial Officer and Principal Accounting Officer
- 274.98K
- Dr. Jeff Patrick, Pharm.D.
- Chief Scientific Officer
- --
- Serguei Melnik
- Chairman of the Board, President and Secretary
- 346.67K
- Sergei Glinka
- Director
- --
- Radu Bujoreanu
- Independent Director
- 40.66K
- Dr. Stefani C. Mancas, PhD
- Independent Director
- 32.31K
- Irina Gram
- Independent Director
- 32.31K
- Mark Hamilton
- Independent Director
- 32.31K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data